First Time Loading...

Editas Medicine Inc
NASDAQ:EDIT

Watchlist Manager
Editas Medicine Inc Logo
Editas Medicine Inc
NASDAQ:EDIT
Watchlist
Price: 6.12 USD 7.75%
Updated: May 15, 2024

Editas Medicine Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Editas Medicine Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Editas Medicine Inc
NASDAQ:EDIT
PP&E Gross
$44.7m
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5B
CAGR 3-Years
-2%
CAGR 5-Years
12%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Editas Medicine Inc's PP&E Gross?
PP&E Gross
44.7m USD

Based on the financial report for Mar 31, 2024, Editas Medicine Inc's PP&E Gross amounts to 44.7m USD.

What is Editas Medicine Inc's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
11%

Over the last year, the PP&E Gross growth was -10%. The average annual PP&E Gross growth rates for Editas Medicine Inc have been 1% over the past three years , 11% over the past five years .